Overview
- Neurosurgeons at University of Michigan implanted Paradromics’ Connexus device in a Michigan woman who has lost much of her ability to speak because of a motor neuron disease in early June.
- Connexus is a fully implanted, wireless system that uses 421 microelectrodes on the brain surface and a small transceiver placed under the left clavicle to send neural data to an external receiver.
- The implant was done under the FDA‑authorized Connect‑One early‑feasibility study and the participant will be followed for six years to track long‑term safety and communication performance.
- The patient left the hospital to recover at home and Paradromics and the clinical team plan rehabilitation and data‑collection to teach the device to decode attempted speech and begin showing results within weeks.
- This trial builds on a June 2025 temporary implant that confirmed safe placement and recording, and it adds to a small group of fully implanted wireless BCIs now being tested while raising questions about safety, privacy and future uses.